On March 8, 2021 Oragenics, Inc. (NYSE American: OGEN) ("Oragenics" or the "Company"), reported that Alan Joslyn, Ph.D., President and Chief Executive Officer of Oragenics, will participate in two virtual investment conferences during the month of March, as follows (Press release, Oragenics, MAR 8, 2021, View Source [SID1234576242]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The H.C. Wainwright Global Life Sciences Virtual Conference with one-on-one meetings being held March 9-10, 2021
The Virtual 33rd Annual Roth Conference with one-on-one meetings being held March 15-17, 2021
The Roth Capital Partners presentation will be prerecorded and available in the Investors section of the Company’s website beginning March 9, 2021. Institutional and other investors interested in scheduling a one-on-one meeting with Oragenics during any of these conferences should contact their sales representative at the sponsoring investment bank.